Two days of oats cut LDL cholesterol by about 10 percent Gut microbiome shifts explained much of the lipid benefit Cholesterol reductions persisted for weeks after the diet Cholesterol-lowering ...

Patients who reach lower levels of LDL cholesterol in the years following DES implantation for STEMI are less likely to develop neoatherosclerosis, a known cause of stent failure, according to a post ...

What Is Lerochol, and Why Does It Matter? Lerochol (lerodalcibep-liga) is a new medicine approved by the FDA to help lower elevated levels of low-density lipoprotein cholesterol (LDL-C), often called ...

NEW YORK - Health experts say drinking orange juice might be a simple way to help lower “bad” cholesterol, also known as LDL. Some studies show that natural ingredients in oranges, as well as special ...

Panelists discuss how global LDL thresholds below 55 mg/dL influence care and challenge U.S. practice to evolve. Panelists discuss how international guidelines—particularly European ones—have adopted ...

A new daily pill could reduce bad cholesterol levels by 60%, according to a new study. Enlicitide, which was developed by Merck, lowered "bad" LDL cholesterol by more than half in a global study ...

“Selenium is an essential mineral that helps to support your metabolism, immune system, and cardiovascular health,” says Nasser. “Although needed in small amounts, it’s essential for your overall well ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn LDL cholesterol and triglycerides in patients whose levels refused to budge ...

NEW ORLEANS — Lowering the level of low-density lipoprotein (LDL) cholesterol to below 40 mg/dL — well beneath current poststroke guideline targets — reduced major cardiovascular events without ...

Please provide your email address to receive an email when new articles are posted on . An oral PCSK9 inhibitor lowered LDL cholesterol by up to 60% and improved other lipid parameters at 24 weeks.

Enlicitide, an oral PCSK9 inhibitor, reduced LDL-C by nearly 60% in adults with or at risk for ASCVD. The medication offers a daily oral alternative to injectable PCSK9 inhibitors, potentially ...